Stockscreener 앱 받기
9.78
0.93%
0.09
시간 외 거래:
9.76
-0.02
-0.20%
전일 마감가:
$9.69
열려 있는:
$9.77
하루 거래량:
1.55M
Relative Volume:
1.42
시가총액:
$952.01M
수익:
$1.85M
순이익/손실:
$-95.19M
주가수익비율:
-4.4038
EPS:
-2.2208
순현금흐름:
$-86.88M
1주 성능:
+1.98%
1개월 성능:
+13.46%
6개월 성능:
+86.29%
1년 성능:
+140.89%
1일 변동 폭
$9.4802
$10.04
1주일 범위
$9.35
$10.56
52주 변동 폭
$2.85
$10.56
Anteris Technologies Global Corp Stock (AVR) Company Profile
명칭
Anteris Technologies Global Corp
전화
651-493-0606
주소
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
9.78 | 943.25M | 1.85M | -95.19M | -86.88M | -2.2208 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-12 | 재개 | Cantor Fitzgerald | Overweight |
| 2026-03-11 | 개시 | Wells Fargo | Overweight |
| 2025-01-08 | 개시 | Lake Street | Buy |
| 2025-01-07 | 개시 | Barclays | Overweight |
| 2025-01-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
모두보기
Anteris Technologies Global Corp 주식(AVR)의 최신 뉴스
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 2000 Value Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Price to earnings forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to earnings forward of Anteris Technologies Global Corp. – BOATS:AVR - TradingView
Enterprise value to EBITDA forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies Global Corp. Actuals & Estimates (NASDAQ:AVR) - TradingView
AVR Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to sales forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Issues 45,631 New Shares from Conversion of Unquoted Securities - TipRanks
Anteris adds 23,072 new CDIs to ASX listing - TipRanks
Anteris Technologies Global Corp (AVR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anteris Technologies Global Corp (AVR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Anteris director David Roberts converts RSUs into common stock under long-term incentive plan - TipRanks
Anteris Technologies (AVR) Proxy filing Summary - Quartr
Anteris Technologies Global Corp (AVR) Institutional Confidence - TradingKey
Anteris Technologies Global Corp (AVR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anteris Technologies Global Corp (AVR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anteris Technologies Global Corp (AVR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anteris Technologies Global Corp - TradingKey
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Losses as Development Pipeline ProgressesPretax Income Report - newsline.com
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical InvestmentCore Business Growth - newsline.com
Funds from operations of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares - Stock Titan
Anteris (AVR) CFO exercises options, delivers 39,595 shares for taxes - Stock Titan
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: EPS Misses Estimates Significantly Amid Continued R&D InvestmentGAAP Earnings Report - newsline.com
Anteris Advances DurAVR Program Through ASX 300 Expansion - Kalkine Media
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - marketscreener.com
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - Moomoo
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial - TradingView
Anteris Wins French Clearance to Expand Global DurAVR Heart Valve Trial - TipRanks
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial - Yahoo Finance
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment - marketscreener.com
Anteris Technologies Global Corp. Receives French Regulatory Clearance for Duravr Transcatheter Heart Valve Global Pivotal Trial - marketscreener.com
Anteris Technologies Global Receives French Regulator's Approval for DurAVR Trial in Aortic Stenosis - marketscreener.com
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance - The Manila Times
Severe aortic stenosis patients in France can join Anteris heart valve trial - Stock Titan
Anteris Technologies Global Corp. Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineGuidance vs Actual - newsline.com
Why Is Anteris Technologies (ASX: AVR) Trading Near a 52-Week High? - Kalkine
Insider Scoop: Major Director Buy Signals Fresh Confidence in Anteris Technologies Global Corp. - TipRanks
Anteris Director Susan Knight Buys First Stake in Company - TipRanks
Anteris Investors Shift From ASX CDIs to Nasdaq Common Stock in May - TipRanks
Anteris Technologies (AVR) director purchases 11,000 shares in open market - Stock Titan
AVR PE Ratio & Valuation, Is AVR Overvalued - Intellectia AI
Why Is Anteris Technologies Global Corp. (AVR) Stock Up Today? - Meyka
Anteris Technologies Global Corp (AVR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.52%
자본화:
|
볼륨(24시간):